Business Description
Coral Laboratories Ltd
ISIN : INE683E01017
Share Class Description:
BOM:524506: Shs DematerialisedTotal Employee Number:
197Compare
Compare
Traded in other countries / regions
524506.India IPO Date
2001-12-26Description
Coral Laboratories Ltd is engaged in the pharmaceutical business. The company is involved in the formulation of medicines. The company's dosage form includes tablets, capsules, liquid orals, b-lactam, dry syrup, meter dose inhalers, injectables, drops, sprays, special kits, and others. Its geographical segments include Ethiopia, India, and the Rest of the world.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 23.54 | |||||
Equity-to-Asset | 0.87 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | 0.17 | |||||
Interest Coverage | 76.27 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 5.35 | |||||
Beneish M-Score | -2.47 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.3 | |||||
3-Year EBITDA Growth Rate | 33.3 | |||||
3-Year EPS without NRI Growth Rate | 36.5 | |||||
3-Year Book Growth Rate | 10.5 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 56.39 | |||||
9-Day RSI | 51.62 | |||||
14-Day RSI | 51.38 | |||||
3-1 Month Momentum % | 34.25 | |||||
6-1 Month Momentum % | 25.46 | |||||
12-1 Month Momentum % | 5.77 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 6.48 | |||||
Quick Ratio | 5.73 | |||||
Cash Ratio | 3.73 | |||||
Days Inventory | 145.44 | |||||
Days Sales Outstanding | 126.67 | |||||
Days Payable | 77.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.26 | |||||
Dividend Payout Ratio | 0.03 | |||||
Forward Dividend Yield % | 0.26 | |||||
5-Year Yield-on-Cost % | 0.26 | |||||
Shareholder Yield % | 0.72 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 58.63 | |||||
Operating Margin % | 15.23 | |||||
Net Margin % | 19.07 | |||||
EBITDA Margin % | 29.6 | |||||
FCF Margin % | -9.22 | |||||
OCF Margin % | 18.18 | |||||
ROE % | 7.88 | |||||
ROA % | 6.99 | |||||
ROIC % | 6.44 | |||||
3-Year ROIIC % | -60.33 | |||||
ROC (Joel Greenblatt) % | 21.42 | |||||
ROCE % | 11.01 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 12.6 | |||||
PE Ratio without NRI | 12.6 | |||||
Shiller PE Ratio | 12.69 | |||||
Price-to-Owner-Earnings | 14.21 | |||||
PEG Ratio | 0.86 | |||||
PS Ratio | 2.4 | |||||
PB Ratio | 0.99 | |||||
Price-to-Tangible-Book | 0.99 | |||||
Price-to-Operating-Cash-Flow | 13.22 | |||||
EV-to-EBIT | 4.68 | |||||
EV-to-EBITDA | 4.28 | |||||
EV-to-Revenue | 1.27 | |||||
EV-to-FCF | -13.76 | |||||
Price-to-GF-Value | 1.2 | |||||
Price-to-Projected-FCF | 1.43 | |||||
Price-to-Median-PS-Value | 1.44 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.77 | |||||
Price-to-Graham-Number | 0.74 | |||||
| Price-to-Net-Current-Asset-Value | 1.42 | |||||
| Price-to-Net-Cash | 2.94 | |||||
Earnings Yield (Greenblatt) % | 21.37 | |||||
FCF Yield % | -3.83 | |||||
Forward Rate of Return (Yacktman) % | 13.93 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Coral Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 858.997 | ||
| EPS (TTM) (₹) | 45.86 | ||
| Beta | 1.3711 | ||
| 3-Year Sharpe Ratio | 0.62 | ||
| 3-Year Sortino Ratio | 1.29 | ||
| Volatility % | 50.44 | ||
| 14-Day RSI | 51.38 | ||
| 14-Day ATR (₹) | 23.942345 | ||
| 20-Day SMA (₹) | 578.81 | ||
| 12-1 Month Momentum % | 5.77 | ||
| 52-Week Range (₹) | 360 - 659 | ||
| Shares Outstanding (Mil) | 3.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Coral Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Coral Laboratories Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| INR 1.500000 Cash Dividend | 2025-09-19 | 534.95 (+2.68%) | ||
| INR 2.000000 Cash Dividend | 2024-09-20 | 895.00 (+0.27%) |
Show
Entries
Coral Laboratories Ltd Frequently Asked Questions
What is Coral Laboratories Ltd(BOM:524506)'s stock price today?
The current price of BOM:524506 is ₹577.90. The 52 week high of BOM:524506 is ₹659.00 and 52 week low is ₹360.00.
When is next earnings date of Coral Laboratories Ltd(BOM:524506)?
The next earnings date of Coral Laboratories Ltd(BOM:524506) is .
Does Coral Laboratories Ltd(BOM:524506) pay dividends? If so, how much?
The Dividend Yield %  of Coral Laboratories Ltd(BOM:524506) is 0.26% (As of Today), Highest Dividend Payout Ratio of Coral Laboratories Ltd(BOM:524506) was 0.14. The lowest was 0.03. And the median was 0.07. The  Forward Dividend Yield % of Coral Laboratories Ltd(BOM:524506) is 0.26%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Coral Laboratories Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers